Exclusive License AgreementExclusive License Agreement • March 16th, 2020 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • Delaware
This Exclusive License Agreement (this “Agreement”) is entered into as of the 3rd day of February, 2020 (the “Effective Date”), by and between EyePoint Pharmaceuticals, Inc., a Delaware corporation having offices at 480 Pleasant Street, Watertown, MA 02472 (“EyePoint”), and Equinox Science, LLC, a Delaware limited liability company having offices at 11780 U.S. Hwy One, Suite 202, Palm Beach Gardens, FL 33408 (“Equinox”). EyePoint and Equinox are each referred to herein by name or as a “Party” or, collectively, as “Parties.”
